Skip to main content
Satyajit Kosuri, MD, Oncology, Chicago, IL

Satyajit Kosuri MD


Physician

Join to view full profile
  • 5841 S Maryland AveChicago, IL 60637

  • Phone+1 888-824-0200

  • Fax+1 773-702-3163

Dr. Kosuri is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2011 - 2014
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2007 - 2010
  • Ross University School of Medicine
    Ross University School of MedicineClass of 2006

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2016 - 2026
  • NY State Medical License
    NY State Medical License 2012 - 2018

Publications & Presentations

PubMed

Abstracts/Posters

  • Outcomes of IDH-Mutated Advanced Phase Ph-Negative Myeloproliferative Neoplasms
    Satyajit Kosuri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Decades in the Making, Cancer Immunotherapy Is on the Rise
    Decades in the Making, Cancer Immunotherapy Is on the RiseAugust 4th, 2025
  • Clinical Trial to Study New Use for CAR T-cell Therapy: Treating Autoimmune Diseases
    Clinical Trial to Study New Use for CAR T-cell Therapy: Treating Autoimmune DiseasesJanuary 21st, 2025
  • Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t Get Meds
    Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t Get MedsJune 22nd, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: